| Literature DB >> 35329038 |
Jeong Suk Jeon1, Sang Yeoup Lee2,3, Soon Cheol Ahn4, Yun Jin Kim5, Jeong Gyu Lee5, Yu Hyeon Yi5.
Abstract
Metabolic syndrome (MetS) is a disease with a high prevalence that threatens the health of modern people. Patient education is essential to control MetS. This prospective study aimed to evaluate 6-month changes in health indicators following a two-day education program for patients with MetS aged 45 or older. Education about MetS, lifestyle modification, nutrition, and physical activity was provided. At 3 and 6 months after the program, participants visited for follow-up. Twenty-two patients completed the 6-month study. Waist circumference was reduced, and life quality and depression index improved in 3 and 6 months compared to pre-education. Blood pressure decreased, and anxiety index improved at three months. Nutritional knowledge was well maintained for 3 and 6 months. High-density lipoprotein-cholesterol levels increased at six months. Three out of twenty-two patients did not satisfy MetS criteria at the end of the study due to improved indicators. A two-day multidisciplinary education program positively affected health indicators in MetS patients. Participation in the program also help with life satisfaction and positive emotional condition. However, some indicators improved in 3 months, but the effect disappeared 6 months after the program.Entities:
Keywords: education; health; metabolic syndrome; nutrition; patient; physical activity
Mesh:
Year: 2022 PMID: 35329038 PMCID: PMC8951422 DOI: 10.3390/ijerph19063351
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1A two-day multidisciplinary education camp program.
Figure 2Flow diagram of study. BMI, body mass index; WC, waist circumference; BP, blood pressure.
Pre-education data of the study population (n = 22).
| Variables | Baseline | |
|---|---|---|
| Age (years) | 62.1 ± 6.0 | |
| Women | 20 (90.9) | |
| Comorbidities | Hypertension | 16 (72.7) |
| Diabetes | 4 (18.2) | |
| Dyslipidemia | 16 (72.7) | |
Values are expressed as the means ± standard deviations (SD) or number (%).
Results of pre- and post-camp data.
| Variables | Pre-Camp | Post-Camp | ||
|---|---|---|---|---|
| Baseline | 3 Months | 6 Months | ||
| Health indices | Weight (kg) | 57.9 (54.3–67.9) | 57.9 (53.7–67.6) | 57.9 (54.4–68.7) |
| Body Mass Index (kg/m2) | 24.6 (22.4–26.9) | 24.1 (22.1–26.7) | 24.0 (21.9–26.8) | |
| Waist Circumference (cm) | 89.0 (85.3–91.8) | 85.0 (79.3–89.9) ** | 86.0 (78.3–91.5) ** | |
| Body Fat (%) | 31.0 (29.8–33.5) | 30.0 (29.7–33.4) | 30.5 (29.5–34.2) | |
| Systolic BP (mmHg) | 131.0 (126.5–140.8) | 130.0 (118.5–134.8) * | 137.0 (131.0–144.0) | |
| Diastolic BP (mmHg) | 76.0 (70.3–80.0) | 73.0 (66.0–77.5) * | 82.0 (73.0–87.0) | |
| Quality of life | EuroQol 5-dimension Scale | 0.96 (0.87–0.96) | 1.00 (0.92–1.00) * | 0.96 (0.96–1.00) * |
| EuroQol 5 VAS | 70.0 (50.0–80.0) | 70.0 (66.3–90.0) * | 80.0 (70.0–88.8) * | |
| BEPSI-K | 20.0 (15.5–22.0) | 21.0 (19.0–23.0) | 21.0 (20.0–24.0) | |
| Emotional conditions | Beck Depression Inventory | 8.0 (3.5–20.8) | 6.0 (2.0–10.0) ** | 5.0 (2.3.0–10.8) * |
| Beck Anxiety Inventory | 12.0 (4.0–19.8) | 6.0 (2.0–10.0) * | 6.0 (2.3–10.8) | |
| Physical activity | International Physical Activity Questionnaire (METs) | 3150.0 (1811.8–4047.0) | 2586.0 (1037.3–3726.8) | 3132.0 (1707.0–4150.5) |
| Disease knowledge | Nutritional Knowledge Questionnaire | 8.0 (7.0–9.8) | 9.0 (8.0–10.8) ** | 9.0 (9.0–11.0) ** |
| Disease markers | Fasting Glucose (mg/dL) | 90.0 (84.3–97.8) | 110.0 (93.8–131.0) ** | |
| Total Cholesterol (mg/dL) | 162.0 (142.0–183.0) | 171.0 (156.0–193.5) * | ||
| HDL Cholesterol (mg/dL) | 45.0 (36.8–53.0) | 49.0 (40.0–60.5) ** | ||
| Triglyceride (mg/dL) | 108.0 (68.0–137.0) | 136.0 (102.3–229.8) ** | ||
| LDL Cholesterol (mg/dL) | 93.0 (69.0–115.0) | 88.5 (68.0–108.0) | ||
| HbA1c (%) | 5.4 (5.3–5.6) | 5.6 (5.5–5.8) ** | ||
Results are presented as median (interquartile range). BP, blood pressure; VAS, visual analogue scale; BEPSI-K, Korean version of the Brief Encounter Psychosocial Instrument; MET, metabolic equivalent task; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c, hemoglobin A1C. * < 0.05, ** < 0.01, as compared with baseline values by Wilcoxon signed-rank test.
Summary of Wilcoxon signed-rank test results.
| Negative Ranks | Positive Ranks | Test Results | ||||
|---|---|---|---|---|---|---|
|
| Mean Rank |
| Mean Rank | Z | ||
| WC (baseline)–WC (3 mo) | 18 | 12.78 | 4 | 5.75 | –3.368 | 0.001 |
| WC (baseline)–WC (6 mo) | 16 | 13.38 | 6 | 6.50 | –2.847 | 0.004 |
| SBP (baseline)–SBP (3 mo) | 14 | 13.25 | 7 | 6.50 | –2.435 | 0.015 |
| DBP (baseline)–DBP (3 mo) | 16 | 11.75 | 5 | 8.60 | –2.523 | 0.012 |
| EQ-5D (baseline)–EQ-5D (3 mo) | 3 | 8.67 | 13 | 8.46 | –2.181 | 0.029 |
| EQ-5D (baseline)–EQ-5D (6 mo) | 3 | 9.00 | 13 | 8.38 | –2.125 | 0.034 |
| EQ VAS (baseline)–EQ VAS (3 mo) | 3 | 7.50 | 12 | 8.13 | –2.157 | 0.031 |
| EQ VAS (baseline)–EQ VAS (6 mo) | 6 | 5.00 | 12 | 11.75 | –2.432 | 0.015 |
| BDI (baseline)–BDI (3 mo) | 15 | 12.67 | 6 | 6.83 | –2.594 | 0.009 |
| BDI (baseline)–BDI (6 mo) | 14 | 12.29 | 6 | 6.33 | –2.510 | 0.012 |
| BAI (baseline)–BAI (3 mo) | 16 | 11.25 | 5 | 10.20 | –2.248 | 0.025 |
| NKQ (baseline)–NKQ (3 mo) | 3 | 5.00 | 13 | 9.31 | –2.781 | 0.005 |
| NKQ (baseline)–NKQ (6 mo) | 2 | 7.00 | 17 | 10.35 | –3.286 | 0.001 |
| FG (baseline)–FG (6 mo) | 5 | 5.60 | 15 | 12.13 | –2.875 | 0.004 |
| TC (baseline)–TC (6 mo) | 5 | 11.00 | 17 | 11.65 | –2.322 | 0.020 |
| HDL-C (baseline)–HDL-C (6 mo) | 4 | 10.88 | 18 | 11.64 | –2.699 | 0.007 |
| TG (baseline)–TG (6 mo) | 4 | 6.38 | 17 | 12.09 | –3.128 | 0.002 |
| HbA1c (baseline)–HbA1c (6 mo) | 3 | 9.50 | 18 | 11.25 | –3.041 | 0.002 |
WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; EQ-5D, EuroQol 5-dimension scale; EQ VAS, EuroQol visual analogue scale; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; NKQ, Nutritional Knowledge Questionnaire; FG, fasting glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HbA1c, hemoglobin A1C. p-value, compared with baseline values by Wilcoxon signed-rank test.